Aprepitant Shortage Update: What Patients Need to Know in 2026

Aprepitant Shortage Update: What Patients Need to Know in 2026

If you've had trouble finding Aprepitant — the anti-nausea medication prescribed before chemotherapy and surgery — you're probably wondering whether there's an official shortage and when things will get better.

Here's what we know as of March 2026, including the current supply situation, pricing, and your best options for finding Aprepitant in stock.

Is Aprepitant Still in Shortage?

As of early 2026, oral Aprepitant is not listed on the FDA's active drug shortage database. That's the good news. Generic Aprepitant capsules — available from manufacturers like Sandoz and Glenmark — have generally maintained a stable supply.

However, the reality on the ground can be different from what federal databases show. Many patients still report difficulty finding Aprepitant at their local pharmacy. Here's why:

• IV Fosaprepitant (the injectable version) has experienced intermittent supply constraints since 2022-2023, and when the IV form is scarce, demand for oral capsules increases
• Distributor allocation limits mean pharmacies may only receive a fraction of what they order during tight supply periods
• Low pharmacy stocking — because Aprepitant is a specialty drug used mainly in oncology, many retail pharmacies simply don't keep it on hand

The bottom line: while there's no official nationwide shortage of oral Aprepitant, finding it at your local pharmacy can still be a challenge.

Why Is Aprepitant Hard to Find?

Several factors contribute to the difficulty:

Manufacturing and Supply Chain Issues

The pharmaceutical supply chain has faced ongoing disruptions in recent years. Active ingredient sourcing, quality control requirements, and production capacity all affect how much Aprepitant reaches pharmacy shelves. When one manufacturer experiences delays, the remaining suppliers face increased demand they may not be able to meet immediately.

Specialty Drug Stocking Patterns

Unlike everyday medications such as blood pressure or diabetes drugs, Aprepitant is prescribed in relatively short courses (typically 2-3 days per chemotherapy cycle). This means pharmacies order it less frequently and keep smaller quantities on hand. A single patient filling a prescription can deplete a pharmacy's entire stock.

Insurance Barriers

Some insurance plans require prior authorization for Aprepitant, especially brand-name Emend. These delays can create a chain reaction — by the time your authorization is approved, the pharmacy may have already dispensed its limited supply to other patients.

For a deeper look at the causes, read our article on why Aprepitant is so hard to find in 2026.

How Much Does Aprepitant Cost in 2026?

Pricing depends on whether you're getting generic or brand-name Aprepitant and whether you have insurance:

• Generic Aprepitant capsules: Average retail price around $100 for a 3-day supply, but as low as $25 with a coupon from GoodRx, SingleCare, or RxSaver
• Emend Tripack (brand): Approximately $180-$500+ without insurance, depending on the pharmacy
• With insurance: Most commercial plans and Medicare Part D cover generic Aprepitant on Tier 2 or Tier 3, with co-pays typically ranging from $10-$50

If cost is a barrier, check out our complete guide on how to save money on Aprepitant, including manufacturer programs and patient assistance.

New Options and Developments

The anti-nausea medication landscape continues to evolve. Here are some developments worth knowing about:

• Multiple generic manufacturers now produce Aprepitant capsules, which helps stabilize supply and keep prices competitive
• Aponvie — a newer injectable formulation of Aprepitant — provides another IV option alongside Cinvanti and Fosaprepitant
• Akynzeo (Netupitant/Palonosetron) — a combination NK1/5-HT3 antagonist — offers a convenient single-dose alternative that your doctor may suggest

For a full rundown of alternatives, see our guide on alternatives to Aprepitant.

How to Find Aprepitant in Stock

Here's your action plan:

1. Check Medfinder

Use Medfinder to see real-time pharmacy availability near you. It's the quickest way to find out who has Aprepitant on the shelf right now.

2. Call Independent and Specialty Pharmacies

Independent pharmacies and oncology specialty pharmacies often have better access to Aprepitant than big chains. They use multiple distributors and can sometimes source medications that chain pharmacies can't.

3. Ask Your Oncology Clinic

Many cancer centers stock Aprepitant directly or can administer IV Fosaprepitant or Cinvanti during your treatment. This may be the most convenient option if your retail pharmacy is out.

4. Plan Ahead

Fill your prescription at least 5-7 days before your chemo session. This gives the pharmacy time to order the medication if needed and gives you a buffer to find alternatives.

For detailed step-by-step advice, read our guide on how to find Aprepitant in stock near you.

Final Thoughts

While oral Aprepitant isn't officially in a nationwide shortage in 2026, finding it at your local pharmacy can still require some effort. Supply chain fluctuations, limited pharmacy stocking, and insurance hurdles all play a role.

The most important thing you can do is plan ahead and use the right tools. Start with Medfinder to check availability, reach out to independent pharmacies, and communicate early with your oncology team.

Preventing nausea during chemotherapy is critical for your treatment and quality of life. Don't let a pharmacy stock-out derail your plan — there are multiple paths to getting the medication you need.